期刊文献+

燧心胶囊对慢性心力衰竭患者血清脑钠肽与心功能的影响 被引量:7

下载PDF
导出
摘要 目的:观察燧心胶囊对慢性心力衰竭患者血清脑钠肽水平与心功能的影响。方法:将60例慢性心力衰竭患者随机分为治疗组、对照组各30例。对照组给予西医常规治疗,治疗组在西医常规治疗基础上加用燧心胶囊,30天为1个疗程,连续观察3个疗程。观察2组总体疗效、中医证候积分的变化;用心脏彩超观察左室舒张末内径、左室射血分数、心脏指数的变化;采用ELISA法检测血清BNP水平。结果:治疗组有效率为83.33%,优于对照组的70.00%(P<0.05),治疗组中医症候积分低于对照组(P<0.05),两组均能缩小左室舒张末内径、提高左室射血分数与心脏指数,降低血清BNP水平,治疗组优于对照组(P<0.05,P<0.01)。结论:在慢性心力衰竭常规治疗基础上加用燧心胶囊,有助于改善患者的临床症状,提高左室射血分数,降低血清BNP水平,其疗效优于单纯西药治疗。
出处 《中医药学报》 CAS 2010年第2期71-73,共3页 Acta Chinese Medicine and Pharmacology
基金 黑龙江省教育厅科学技术研究项目(编号:11531352)
  • 相关文献

参考文献5

二级参考文献30

  • 1高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量:65
  • 2Sagnella GA.Mearement and significance of circulating natriuretic peptides in cardiovascular disease.Clin Sci,1998,95:519-529.
  • 3Hystad ME,Geiran OR,Attramadal H,et al.Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.Acta Physiol Scand,2001,171:395-403.
  • 4Goto T,Takase H,Toriyama T,et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.Heart,2003,89:1303-1307.
  • 5Hobbs RE,Miller LW,Bott-Silverman C,et al.Hemodynamic effects of a single Intravenous Injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol,1996,78:896
  • 6Mills RM,LeJemtel TH,Horton DP,et al.Sustainded hemodynamic effects of an Infusion of nesiritide(human B-type natriuretic peptide)in heart failure.J Am Coll Cardiol,1999,34:155-162.
  • 7Colucci WS,Elkayam U,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated congestive heart failure.N Engl J Med,2000,343:896.
  • 8Burger AJ,Elkayam U,Neibaur MT,et al.Comparison of the occurrence of ventricular arrhythmias in patients with acutely decornpensated congestive heart failure receiving dobutamine versus nesiritide therapy.Am J Cardiol,2001,88 :35-39.
  • 9Publication Committee for the VMAC Investigators.Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure-a randomized controlled trial.JAMA,2002,287:1531-1535.
  • 10U.S.Food and Drug Administration.The Food and Drug Administration( FDA)has approved Natrecor(nesiritide)Injection for the treatment of acute congestive heart failure(CHF).New York:FDA Talk Paper,2001.T01-T36.

共引文献80

同被引文献29

  • 1郭继鸿.窦性心律震荡现象[J].临床心电学杂志,2003,12(1):49-54. 被引量:310
  • 2陈灏珠.心率变异性的测定及其临床意义[J].临床心电学杂志,1994,3(4):168-172. 被引量:102
  • 3郝迪,尹向东,刘小雷.心力衰竭与心肌细胞凋亡[J].内蒙古医学院学报,2006,28(3):246-249. 被引量:4
  • 4何怀阳,黄春林.心衰中医病机探讨[J].辽宁中医杂志,2007,34(4):413-415. 被引量:35
  • 5陈琛,何梦,陈劢.慢性心力衰竭患者的心率变异性分析[J].心电学杂志,2007,26(2):79-81. 被引量:17
  • 6中华医学会心血管病学分会.中华心血管病杂志编辑委员会,慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,.
  • 7Szymanowska K, Piatkowska A, Nowicka A, et al. Clinical significance of heart rate turbulence assessment in Patients with chronic heart failure [ J ]. Kardiol Pol,2008,66 ( 12 ) : 1289 - 1295.
  • 8Sealvini S, Volterrani M, Zanelli E, et al. Is heart rate variability a reliable method to assess autonomic modulation in left ventficular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability, lnt J Cardiol.1998.67( 1 ) :9.
  • 9Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end- stage heart failure. N Engl J Mecl, 1996,335:1182-1189.
  • 10Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart, bl Engl J Med,1997,336:1131-1141.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部